Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Yury Gerasimenko
University of California Los Angeles, Department: Neurosurgery
Should you be removed from our database? Contact us at [email protected]. Read more below.
NeuroRecovery Technologies
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution
Professor Gerasimenko disclosed he owns NRT stock valued at (b)(4) and is co-inventor of intellectual property owned by The Regents which will be used as a research tool on this project. NRT is the result of a tech transfer from UCLA, Caltech and the University of Louisville focusing on implantable technology. It is currently developing methods and devices to stimulate and neuro-modulate the spinal cord to restore loss of function as the result of paralysis, regardless of the underlying cause. NRT is currently being united under a holding company with NeuroEnabling Technology, under which each will be a subsidiary.
Enabling forelimb function with agonist drug and epidural stimulation in SCI
It now seems possible to apply three interventions (epidural stimulation, administration of pharmacological agents, and motor training) to control the excitability of localized neural circuits in humans with a cervical spinal cord injury (SCI), thus enabling these individuals to regain use of their arms and hands. This enabling effect is similar to that observed with improved postural and locomotor function after a mid-thoracic SCI. We will reach critical milestones that will provide the basis for a series of clinical trials for furter defining the efficacy of these interventions.
Filed on July 12, 2013.
Tell us what you know about Yury Gerasimenko's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Yury Gerasimenko”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Yury Gerasimenko | University of California Los Angeles | Conflict of Interest | NeuroRecovery Technologies | $5,000 - $9,999 |
| Yury Gerasimenko | University of California Los Angeles | Conflict of Interest | NeuroRecovery Technologies | $0 - $4,999 |
| Yury Gerasimenko | University of California Los Angeles | Conflict of Interest | NeuroRecovery Technologies | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.